Skip to main content

Soliris 300 mg/30 mL (10 mg/mL) injection Images

Generic Name: eculizumab

This medication has been identified as Soliris 300 mg/30 mL (10 mg/mL) injection. It is supplied by Alexion Pharmaceuticals Inc.

Soliris is used in the treatment of Hemolytic Uremic Syndrome; Myasthenia Gravis; Neuromyelitis Optica Spectrum Disorder; Paroxysmal Nocturnal Hemoglobinuria and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Soliris 300 mg/30 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Soliris 300 mg/30 mL (10 mg/mL) injection medicine

Soliris

Generic Name
eculizumab
Strength
300 mg/30 mL (10 mg/mL) injection
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alexion Pharmaceuticals Inc.
National Drug Code (NDC)
25682-0001

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.